Latigo surges 17% after raising $345.6 million in upsized IPO

JEF -1.92%

1. 1Shares of Latigo Biotherapeutics (LTGO), a clinical-stage developer of non-opioid pain treatments, jumped 17% on Friday following its upsized initial public offering.
2. 2The company sold 19.2 million shares at the top of the marketed range at $18, raising $345.6 million, and opened trading at $21.
3. 3Backed by Blue Owl Capital, the company has a market capitalization of roughly $1.3 billion, joining this quarter's wave of biotech listings.

Source Bloomberg · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →